Global hydroxychloroquine and chloroquine market is expected to grow at a robust pace during the forecast period, with the market size expected to double in 2020. Hydroxychloroquine and chloroquine are commonly available in the market under the brand name Aralen and Plaquenil, respectively. Several other formulations of hydroxychloroquine and chloroquine are also available that are sold under different brand names. Chemically, chloroquine is 7-chloro-4-[[4-(diethylamino)-1-methylbutyl] amino] quinoline phosphate (1:2) and is used for the treatment of various diseases such as rheumatoid arthritis, malaria and others.

The global hydroxychloroquine and chloroquine market are driven by the increase in prevalence of COVID-19. In 2019, the market stood at approximately $ 140 million and is expected to reach $ 285 million in 2020. In the recent light of events, FDA issued an Emergency Use Authorization for the treatment of novel coronavirus disease (COVID-19).

Hydroxychloroquine and Chloroquine phosphate belong to the class of antimalarial, amebicides drugs. One of the major applications of Hydroxychloroquine and Chloroquine is for the prevention and treatment of malaria. Globally, Ipca and Cadila are among the top manufacturers of these drugs. The US FDA has recently lifted import alerts on its plants, paving the way for the firms to export the drugs to the US. India is among the major manufacturers of the world’s total hydroxychloroquine production and exported worth USD51 million of Hydrochloroquine  and Chloroquine and in 2019. China, being the largest manufacturer of APIs, is not producing Hydroxychloroquine because of less cases of malaria.

The global hydroxychloroquine and chloroquine market is segmented based on type, route of administration, strength, application, and region. Based on application, the market can be categorized into rheumatoid arthritis, malaria, COVID-19 and others. In the application segments, COVID-19 is expected to dominate the market due to rising prevalence of this disease.

Furthermore, based on type, the tablet segment is expected to dominate the market due to its cost effectiveness. Among all regions, North America is expected to witness significant growth during the forecast period in the overall hydroxychloroquine and chloroquine market owing to comparatively higher prevalence of COVID-19 .

Major players operating in the global chloroquine market include Ipca Laboratories Ltd, Zydus Cadila, Novartis AG, Teva Pharmaceutical Industries Ltd., Bayer AG, Rising Pharma Holdings Inc, Abcam plc, Mylan N.V, Abbott and others

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021–2030

Objective of the Study:

  • To analyze and forecast the market size of global hydroxychloroquine and chloroquine market.
  • To classify and forecast global hydroxychloroquine and chloroquine market based on type, route of administration, strength, application, company and regional distribution.
  • To identify drivers and challenges for global hydroxychloroquine and chloroquine market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global hydroxychloroquine and chloroquine market.
  • To conduct pricing analysis for global hydroxychloroquine and chloroquine market.
  • To identify and analyze the profile of leading players operating in global hydroxychloroquine and chloroquine market.
  • To examine policy & regulatory landscape for global hydroxychloroquine and chloroquine market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hydroxychloroquine and chloroquine manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players operating across the globe.

TechSci Research calculated the market size of global hydroxychloroquine and chloroquine market using a bottom-up approach, wherein data for various segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.


Key Target Audience:

  • Hydroxychloroquine and chloroquine manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to chloroquine
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global hydroxychloroquine and chloroquine market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Type:
    • Injectables
    • Tablets
  • Market, By Route of Administration:
    • Oral
    • Intravenous
  • Market, By Strength:
    • 100mg
    • 200mg
    • 250mg
    • 500mg
  • Market, By Application:
    • Rheumatoid Arthritis
    • Malaria
    • COVID-19
    • Others
  • Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global hydroxychloroquine and chloroquine market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Route of Administration Overview

2.    Research Methodology

3.    Executive Summary

4.    Voice of Customer

4.1.  Brand Awareness (Aided/Unaided)

4.2.  Route of Administration Awareness

4.3.  Customer Satisfaction Analysis

4.4.  Unmet Needs/Challenges

5.    Global Hydroxychloroquine & Chloroquine Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.2.  Market Share & Forecast

5.2.1.     By Type (Injectables, Tablets)

5.2.2.     By Route of Administration (Oral v/s Intravenous)

5.2.3.     By Strength (100mg,200mg, 250mg, 500mg,)

5.2.4.     By Application (Rheumatoid Arthritis, Malaria, COVID-19, Others)

5.2.5.     By Company (2019)

5.2.6.     By Region

5.3.  Route of Administration Market Map

6.    Asia-Pacific Hydroxychloroquine & Chloroquine Market Outlook

6.1.  Market Size & Forecast          

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Type

6.2.2.     By Application

6.2.3.     By Route of Administration

6.2.4.     By Strength

6.2.5.     By Country

6.3.  Asia-Pacific: Country Analysis

6.3.1.     China Hydroxychloroquine & Chloroquine Market Outlook

6.3.1.1.         Market Size & Forecast

6.3.1.1.1.             By Value

6.3.1.2.         Market Share & Forecast

6.3.1.2.1.             By Type

6.3.1.2.2.             By Application

6.3.1.2.3.             By Route of Administration

6.3.1.2.4.             By Strength

6.3.2.     India Hydroxychloroquine & Chloroquine Market Outlook

6.3.2.1.         Market Size & Forecast

6.3.2.1.1.             By Value

6.3.2.2.         Market Share & Forecast

6.3.2.2.1.             By Type

6.3.2.2.2.             By Application

6.3.2.2.3.             By Route of Administration

6.3.2.2.4.             By Strength

6.3.3.     Australia Hydroxychloroquine & Chloroquine Market Outlook

6.3.3.1.         Market Size & Forecast

6.3.3.1.1.             By Value

6.3.3.2.         Market Share & Forecast

6.3.3.2.1.             By Type

6.3.3.2.2.             By Application

6.3.3.2.3.             By Route of Administration

6.3.3.2.4.             By Strength

6.3.4.     Japan Hydroxychloroquine & Chloroquine Market Outlook

6.3.4.1.         Market Size & Forecast

6.3.4.1.1.             By Value

6.3.4.2.         Market Share & Forecast

6.3.4.2.1.             By Type

6.3.4.2.2.             By Application

6.3.4.2.3.             By Route of Administration

6.3.4.2.4.             By Strength

6.3.5.     South Korea Hydroxychloroquine & Chloroquine Market Outlook

6.3.5.1.         Market Size & Forecast

6.3.5.1.1.             By Value

6.3.5.2.         Market Share & Forecast

6.3.5.2.1.             By Type

6.3.5.2.2.             By Application

6.3.6.     Singapore Hydroxychloroquine & Chloroquine Market Outlook

6.3.6.1.         Market Size & Forecast

6.3.6.1.1.             By Value

6.3.6.2.         Market Share & Forecast

6.3.6.2.1.             By Type

6.3.6.2.2.             By Application

6.3.6.2.3.             By Route of Administration

6.3.6.2.4.             By Strength

7.    Europe Hydroxychloroquine & Chloroquine Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Type

7.2.2.     By Application

7.2.3.     By Route of Administration

7.2.4.     By Strength

7.2.5.     By Country

7.3.  Europe: Country Analysis

7.3.1.     France Hydroxychloroquine & Chloroquine Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Type

7.3.1.2.2.             By Application

7.3.1.2.3.             By Route of Administration

7.3.1.2.4.             By Strength

7.3.2.     Germany Hydroxychloroquine & Chloroquine Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Type

7.3.2.2.2.             By Application

7.3.2.2.3.             By Route of Administration

7.3.2.2.4.             By Strength

7.3.3.     United Kingdom Hydroxychloroquine & Chloroquine Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Type

7.3.3.2.2.             By Application

7.3.3.2.3.             By Route of Administration

7.3.3.2.4.             By Strength

7.3.4.     Italy Hydroxychloroquine & Chloroquine Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Type

7.3.4.2.2.             By Application

7.3.4.2.3.             By Route of Administration

7.3.4.2.4.             By Strength

7.3.5.     Spain Hydroxychloroquine & Chloroquine Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Type

7.3.5.2.2.             By Application

7.3.5.2.3.             By Route of Administration

7.3.5.2.4.             By Strength

8.    North America Hydroxychloroquine & Chloroquine Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Type

8.2.2.     By Application

8.2.3.     By Route of Administration

8.2.4.     By Strength

8.2.5.     By Country

8.3.  North America: Country Analysis

8.3.1.     United States Hydroxychloroquine & Chloroquine Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Type

8.3.1.2.2.             By Application

8.3.1.2.3.             By Route of Administration

8.3.1.2.4.             By Strength

8.3.2.     Mexico Hydroxychloroquine & Chloroquine Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Type

8.3.2.2.2.             By Application

8.3.2.2.3.             By Route of Administration

8.3.2.2.4.             By Strength

8.3.3.     Canada Hydroxychloroquine & Chloroquine Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Type

8.3.3.2.2.             By Application

8.3.3.2.3.             By Route of Administration

8.3.3.2.4.             By Strength

9.    South America Hydroxychloroquine & Chloroquine Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Type

9.2.2.     By Application

9.2.3.     By Route of Administration

9.2.4.     By Strength

9.2.5.     By Country

9.3.  South America: Country Analysis

9.3.1.     Brazil Hydroxychloroquine & Chloroquine Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Type

9.3.1.2.2.             By Application

9.3.1.2.3.             By Route of Administration

9.3.1.2.4.             By Strength

9.3.2.     Argentina Hydroxychloroquine & Chloroquine Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Type

9.3.2.2.2.             By Application

9.3.2.2.3.             By Route of Administration

9.3.2.2.4.             By Strength

9.3.3.     Colombia Hydroxychloroquine & Chloroquine Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Type

9.3.3.2.2.             By Application

9.3.3.2.3.             By Route of Administration

9.3.3.2.4.             By Strength

10.  Middle East and Africa Hydroxychloroquine & Chloroquine Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Type

10.2.2.  By Application

10.2.3.  By Route of Administration

10.2.4.  By Strength

10.2.5.  By Country

10.3.              MEA: Country Analysis

10.3.1.  South Africa Hydroxychloroquine & Chloroquine Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Type

10.3.1.2.2.           By Application

10.3.1.2.3.           By Route of Administration

10.3.1.2.4.           By Strength

10.3.2.  Saudi Arabia Hydroxychloroquine & Chloroquine Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Type

10.3.2.2.2.           By Application

10.3.2.2.3.           By Route of Administration

10.3.2.2.4.           By Strength

10.3.3.  UAE Hydroxychloroquine & Chloroquine Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Type

10.3.3.2.2.           By Application

10.3.3.2.3.           By Route of Administration

10.3.3.2.4.           By Strength

10.3.4.  Kuwait Hydroxychloroquine & Chloroquine Market Outlook

10.3.4.1.      Market Size & Forecast

10.3.4.1.1.           By Value

10.3.4.2.      Market Share & Forecast

10.3.4.2.1.           By Type

10.3.4.2.2.           By Application

10.3.4.2.3.           By Route of Administration

10.3.4.2.4.           By Strength

11.  Market Dynamics

11.1.              Drivers

11.2.              Challenges

12.  Market Trends & Developments

13.  Pricing Analysis

14.  Competitive Landscape

14.1.   Ipca Laboratories Ltd

14.2.   Zydus Cadila

14.3.   Novartis AG

14.4.   Teva Pharmaceutical Industries Ltd

14.5.   Bayer AG

14.6.   Rising Pharma Holdings Inc

14.7.   Abcam plc

14.8.   Mylan N.V

14.9.   Abbott Laboratories

14.10. Artecef B.V.

14.11. Uniprix Inc.

14.12. Recipharm

15.  Strategic Recommendations

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

  • List of Figures

    Figure 1: Global Hydroxychloroquine and Chloroquine Size, By Value (USD Million), 2015-2030F

    Figure 2: Global Hydroxychloroquine and Chloroquine Size, By Type (USD Million), 2015-2030F

    Figure 3: Global Hydroxychloroquine and Chloroquine Share, By Route of Administration (USD Million), 2015-2030F

    Figure 4: Global Hydroxychloroquine and Chloroquine Share, By Application (USD Million), 2015-2030F

    Figure 5: Global Hydroxychloroquine and Chloroquine Share, By Region (USD Million), 2015-2030F

    Figure 6: Global Hydroxychloroquine and Chloroquine Share, By Company (USD Million), 2015-2030F

    Figure 7: Global Hydroxychloroquine and Chloroquine Attractiveness Index, By Region, By Value, 2015-2030F

    Figure 8: Global Hydroxychloroquine and Chloroquine Attractiveness Index, By Route of Administration Type, By Value, 2015-2030F

    Figure 9: North America Hydroxychloroquine and Chloroquine Size, By Value (USD Million), 2015-2030F

    Figure 10: North America Hydroxychloroquine and Chloroquine Size, By Type (USD Million), 2015-2030F

    Figure 11: North America Hydroxychloroquine and Chloroquine Share, By Route of Administration (USD Million), 2015-2030F

    Figure 12: North America Hydroxychloroquine and Chloroquine Share, By Application (USD Million), 2015-2030F

    Figure 13: North America Hydroxychloroquine and Chloroquine Share, By Country (USD Million), 2015-2030F

    Figure 14: North America Hydroxychloroquine and Chloroquine Attractiveness Index, By Country, By Value, 2015-2030F

    Figure 15: North America Hydroxychloroquine and Chloroquine Attractiveness Index, By Route of Administration, By Value, 2015-2030F

    Figure 16: United States Hydroxychloroquine and Chloroquine Size, By Value (USD Million), 2015-2030F

    Figure 17: United States Hydroxychloroquine and Chloroquine Size, By Type, 2015-2030F

    Figure 18: United States Hydroxychloroquine and Chloroquine Share, By Route of Administration, 2015-2030F

    Figure 19: United States Hydroxychloroquine and Chloroquine Share, By Application, 2015-2030F

    Figure 20: United States Hydroxychloroquine and Chloroquine Attractiveness Index, By Route of Administration, By Value, 2015-2030F

    Figure 21: Canada Hydroxychloroquine and Chloroquine Size, By Value (USD Million), 2015-2030F

    Figure 22: Canada Hydroxychloroquine and Chloroquine Size, By Type, 2015-2030F

    Figure 23: Canada Hydroxychloroquine and Chloroquine Share, By Route of Administration, 2015-2030F

    Figure 24: Canada Hydroxychloroquine and Chloroquine Share, By Application, 2015-2030F

    Figure 25: Canada Hydroxychloroquine and Chloroquine Attractiveness Index, By Route of Administration, By Value, 2015-2030F

    Figure 26: Mexico Hydroxychloroquine and Chloroquine Size, By Value (USD Million), 2015-2030F

    Figure 27: Mexico Hydroxychloroquine and Chloroquine Size, By Type, 2015-2030F

    Figure 28: Mexico Hydroxychloroquine and Chloroquine Share, By Route of Administration, 2015-2030F

    Figure 29: Mexico Hydroxychloroquine and Chloroquine Share, By Application, 2015-2030F

    Figure 30:  Mexico Hydroxychloroquine and Chloroquine Attractiveness Index, By Route of Administration, By Value, 2015-2030F

    Figure 31: Europe Hydroxychloroquine and Chloroquine Size, By Value (USD Million), 2015-2030F

    Figure 32:  Europe Hydroxychloroquine and Chloroquine Size, By Type (USD Million), 2015-2030F

    Figure 33:  Europe Hydroxychloroquine and Chloroquine Share, By Route of Administration (USD Million), 2015-2030F

    Figure 34:  Europe Hydroxychloroquine and Chloroquine Share, By Application (USD Million), 2015-2030F

    Figure 35: Europe Hydroxychloroquine and Chloroquine Share, By Country (USD Million), 2015-2030F

    Figure 36: Europe Hydroxychloroquine and Chloroquine Attractiveness Index, By Country, By Value, 2015-2030F

    Figure 37: Europe Hydroxychloroquine and Chloroquine Attractiveness Index, By Route of Administration, By Value, 2015-2030F

    Figure 38:  Russia Hydroxychloroquine and Chloroquine Size, By Value (USD Million), 2015-2030F

    Figure 39: Russia Kingdom Hydroxychloroquine and Chloroquine Size, By Type, 2015-2030F

    Figure 40: Russia Hydroxychloroquine and Chloroquine Share, By Route of Administration, 2015-2030F

    Figure 41:  Russia Hydroxychloroquine and Chloroquine Share, By Application, 2015-2030F

    Figure 42:  Russia Hydroxychloroquine and Chloroquine Attractiveness Index, By Route of Administration, By Value, 2015-2030F

    Figure 43: United Kingdom Hydroxychloroquine and Chloroquine Size, By Value (USD Million), 2015-2030F

    Figure 44: United Kingdom Hydroxychloroquine and Chloroquine Size, By Type, 2015-2030F

    Figure 45: United Kingdom Hydroxychloroquine and Chloroquine Share, By Route of Administration, 2015-2030F

    Figure 46: United Kingdom Hydroxychloroquine and Chloroquine Share, By Application, 2015-2030F

    Figure 47: United Kingdom Hydroxychloroquine and Chloroquine Attractiveness Index, By Route of Administration, By Value, 2015-2030F

    Figure 48: Italy Hydroxychloroquine and Chloroquine Size, By Value (USD Million), 2015-2030F

    Figure 49: Italy Hydroxychloroquine and Chloroquine Size, By Type, 2015-2030F

    Figure 50:  Italy Hydroxychloroquine and Chloroquine Share, By Route of Administration, 2015-2030F

    Figure 51: Italy Hydroxychloroquine and Chloroquine Share, By Application, 2015-2030F

    Figure 52: Italy Hydroxychloroquine and Chloroquine Attractiveness Index, By Route of Administration, By Value, 2015-2030F

    Figure 53: Germany Hydroxychloroquine and Chloroquine Size, By Value (USD Million), 2015-2030F

    Figure 54: Germany Hydroxychloroquine and Chloroquine Size, By Type, 2015-2030F

    Figure 55: Germany Hydroxychloroquine and Chloroquine Share, By Route of Administration, 2015-2030F

    Figure 56: Germany Hydroxychloroquine and Chloroquine Share, By Application, 2015-2030F

    Figure 57: Germany Hydroxychloroquine and Chloroquine Attractiveness Index, By Route of Administration, By Value, 2015-2030F

    Figure 58: Spain Hydroxychloroquine and Chloroquine Size, By Value (USD Million), 2015-2030F

    Figure 59: Spain Hydroxychloroquine and Chloroquine Size, By Type, 2015-2030F

    Figure 60: Spain Hydroxychloroquine and Chloroquine Share, By Route of Administration, 2015-2030F

    Figure 61: Spain Hydroxychloroquine and Chloroquine Share, By Application, 2015-2030F

    Figure 62: Spain Hydroxychloroquine and Chloroquine Attractiveness Index, By Route of Administration, By Value, 2015-2030F

    Figure 63: France Hydroxychloroquine and Chloroquine Size, By Value (USD Million), 2015-2030F

    Figure 64: France Hydroxychloroquine and Chloroquine Size, By Type, 2015-2030F

    Figure 65: France Hydroxychloroquine and Chloroquine Share, By Route of Administration, 2015-2030F

    Figure 66: France Hydroxychloroquine and Chloroquine Share, By Application, 2015-2030F

    Figure 67: France Hydroxychloroquine and Chloroquine Attractiveness Index, By Route of Administration, By Value, 2015-2030F

    Figure 68: Asia – Pacific Hydroxychloroquine and Chloroquine Size, By Value (USD Million), 2015-2030F

    Figure 69: Asia – Pacific   Hydroxychloroquine and Chloroquine Size, By Type(USD Million), 2015-2030F

    Figure 70: Asia – Pacific Hydroxychloroquine and Chloroquine Share, By Route of Administration (USD Million), 2015-2030F

    Figure 71: Asia – Pacific Hydroxychloroquine and Chloroquine Share, By Application (USD Million), 2015-2030F

    Figure 72: Asia – Pacific Hydroxychloroquine and Chloroquine Share, By Country (USD Million), 2015-2030F

    Figure 73: Asia – Pacific Hydroxychloroquine and Chloroquine Attractiveness Index, By Country, By Value, 2015-2030F

    Figure 74: Asia – Pacific Hydroxychloroquine and Chloroquine Attractiveness Index, By Route of Administration, By Value, 2015-2030F

    Figure 75: China Hydroxychloroquine and Chloroquine Size, By Value (USD Million), 2015-2030F

    Figure 76:  China Hydroxychloroquine and Chloroquine Size, By Type, 2015-2030F

    Figure 77: China Hydroxychloroquine and Chloroquine Share, By Route of Administration, 2015-2030F

    Figure 78: China Hydroxychloroquine and Chloroquine Share, By Application, 2015-2030F

    Figure 79: China Hydroxychloroquine and Chloroquine Share, By Strength, 2015-2030F

    Figure 80:  China Hydroxychloroquine and Chloroquine Attractiveness Index, By Route of Administration, By Value, 2015-2030F

    Figure 81: India Hydroxychloroquine and Chloroquine Size, By Value (USD Million), 2015-2030F

    Figure 82: India Hydroxychloroquine and Chloroquine Size, By Type, 2015-2030F

    Figure 83: India Hydroxychloroquine and Chloroquine Share, By Route of Administration, 2015-2030F

    Figure 84: India Hydroxychloroquine and Chloroquine Share, By Application, 2015-2030F

    Figure 85: India Hydroxychloroquine and Chloroquine Attractiveness Index, By Route of Administration, By Value, 2015-2030F

    Figure 86: Australia Hydroxychloroquine and Chloroquine Size, By Value (USD Million), 2015-2030F

    Figure 87: Australia Hydroxychloroquine and Chloroquine Size, By Type, 2015-2030F

    Figure 88: Australia Hydroxychloroquine and Chloroquine Share, By Route of Administration, 2015-2030F

    Figure 89: Australia Hydroxychloroquine and Chloroquine Share, By Application, 2015-2030F

    Figure 90: Australia Hydroxychloroquine and Chloroquine Attractiveness Index, By Route of Administration, By Value, 2015-2030F

    Figure 91: Japan Hydroxychloroquine and Chloroquine Size, By Value (USD Million), 2015-2030F

    Figure 92: Japan Hydroxychloroquine and Chloroquine Size, By Type, 2015-2030F

    Figure 93: Japan Hydroxychloroquine and Chloroquine Share, By Route of Administration, 2015-2030F

    Figure 94: Japan Hydroxychloroquine and Chloroquine Share, By Application, 2015-2030F

    Figure 95: Japan Hydroxychloroquine and Chloroquine Share, By Strength, 2015-2030F

    Figure 96:  Japan Hydroxychloroquine and Chloroquine Attractiveness Index, By Route of Administration, By Value, 2015-2030F

    Figure 97: Singapore Hydroxychloroquine and Chloroquine Size, By Value (USD Million), 2015-2030F

    Figure 98: Singapore Hydroxychloroquine and Chloroquine Size, By Type, 2015-2030F

    Figure 99: Singapore Hydroxychloroquine and Chloroquine Share, By Route of Administration, 2015-2030F

    Figure 100: Singapore Hydroxychloroquine and Chloroquine Share, By Application, 2015-2030F

    Figure 101: Singapore Hydroxychloroquine and Chloroquine Attractiveness Index, By Route of Administration, By Value, 2015-2030F

    Figure 102: South Korea Hydroxychloroquine and Chloroquine Size, By Value (USD Million), 2015-2030F

    Figure 103: South Korea Hydroxychloroquine and Chloroquine Size, By Type, 2015-2030F

    Figure 104: South Korea Hydroxychloroquine and Chloroquine Share, By Route of Administration, 2015-2030F

    Figure 105: South Korea Hydroxychloroquine and Chloroquine Share, By Application, 2015-2030F

    Figure 106: South Korea Hydroxychloroquine and Chloroquine Share, By Strength, 2015-2030F

    Figure 107: South Korea Hydroxychloroquine and Chloroquine Attractiveness Index, By Route of Administration, By Value, 2015-2030F

    Figure 108:  Middle East and Africa Hydroxychloroquine and Chloroquine Size, By Value (USD Million), 2015-2030F

    Figure 109:  Middle East and Africa Hydroxychloroquine and Chloroquine Size, By Type(USD Million), 2015-2030F

    Figure 110:  Middle East and Africa Hydroxychloroquine and Chloroquine Share, By Route of Administration (USD Million), 2015-2030F

    Figure 111: Middle East and Africa Hydroxychloroquine and Chloroquine Share, By Application (USD Million), 2015-2030F

    Figure 112: Middle East and Africa   Hydroxychloroquine and Chloroquine Share, By Country (USD Million), 2015-2030F

    Figure 113: Middle East and Africa Hydroxychloroquine and Chloroquine Attractiveness Index, By Country, By Value, 2015-2030F

    Figure 114: Middle East and Africa Hydroxychloroquine and Chloroquine Attractiveness Index, By Route of Administration, By Value, 2015-2030F

    Figure 115: Saudi Arabia Hydroxychloroquine and Chloroquine Size, By Value (USD Million), 2015-2030F

    Figure 116: Saudi Arabia Hydroxychloroquine and Chloroquine Size, By Type, 2015-2030F

    Figure 117: Saudi Arabia Hydroxychloroquine and Chloroquine Share, By Route of Administration, 2015-2030F

    Figure 118: Saudi Arabia Hydroxychloroquine and Chloroquine Share, By Application, 2015-2030F

    Figure 119: Saudi Arabia Hydroxychloroquine and Chloroquine Attractiveness Index, By Route of Administration, By Value, 2015-2030F

    Figure 120: UAE Hydroxychloroquine and Chloroquine Size, By Value (USD Million), 2015-2030F

    Figure 121: UAE Hydroxychloroquine and Chloroquine Size, By Type, 2015-2030F

    Figure 122: UAE Hydroxychloroquine and Chloroquine Share, By Route of Administration, 2015-2030F

    Figure 123: UAE Hydroxychloroquine and Chloroquine Share, By Application, 2015-2030F

    Figure 124: UAE Hydroxychloroquine and Chloroquine Share, By Strength, 2015-2030F

    Figure 125: UAE Hydroxychloroquine and Chloroquine Attractiveness Index, By Route of Administration, By Value, 2015-2030F

    Figure 126: South Africa Hydroxychloroquine and Chloroquine Size, By Value (USD Million), 2015-2030F

    Figure 127: South Africa Hydroxychloroquine and Chloroquine Size, By Type, 2015-2030F

    Figure 128: South Africa Hydroxychloroquine and Chloroquine Share, By Route of Administration, 2015-2030F

    Figure 129: South Africa Hydroxychloroquine and Chloroquine Share, By Application, 2015-2030F

    Figure 130: South Africa Hydroxychloroquine and Chloroquine Share, By Strength, 2015-2030F

    Figure 131: South Africa Hydroxychloroquine and Chloroquine Attractiveness Index, By Route of Administration, By Value, 2015-2030F

    Figure 132: Kuwait Hydroxychloroquine and Chloroquine Size, By Value (USD Million), 2015-2030F

    Figure 133: Kuwait Hydroxychloroquine and Chloroquine Size, By Type, 2015-2030F

    Figure 134: Kuwait Hydroxychloroquine and Chloroquine Share, By Route of Administration, 2015-2030F

    Figure 135: Kuwait Hydroxychloroquine and Chloroquine Share, By Application, 2015-2030F

    Figure 136: Kuwait Hydroxychloroquine and Chloroquine Share, By Strength, 2015-2030F

    Figure 137: Kuwait Hydroxychloroquine and Chloroquine Attractiveness Index, By Route of Administration, By Value, 2015-2030F

    Figure 138:  South America Hydroxychloroquine and Chloroquine Size, By Value (USD Million), 2015-2030F

    Figure 139:  South America Hydroxychloroquine and Chloroquine Size, By Type (USD Million), 2015-2030F

    Figure 140:  South America Hydroxychloroquine and Chloroquine Share, By Route of Administration (USD Million), 2015-2030F

    Figure 141: South America Hydroxychloroquine and Chloroquine Share, By Application (USD Million), 2015-2030F

    Figure 142: South America Hydroxychloroquine and Chloroquine Share, By Country (USD Million), 2015-2030F

    Figure 143: South America Hydroxychloroquine and Chloroquine Attractiveness Index, By Country, By Value, 2015-2030F

    Figure 144: South America Hydroxychloroquine and Chloroquine Attractiveness Index, By Route of Administration, By Value, 2015-2030F

    Figure 145: Brazil Hydroxychloroquine and Chloroquine Size, By Value (USD Million), 2015-2030F

    Figure 146: Brazil Hydroxychloroquine and Chloroquine Size, By Type, 2015-2030F

    Figure 147: Brazil Hydroxychloroquine and Chloroquine Share, By Route of Administration, 2015-2030F

    Figure 148: Brazil Hydroxychloroquine and Chloroquine Share, By Application, 2015-2030F

    Figure 149: Brazil Hydroxychloroquine and Chloroquine Share, By Strength, 2015-2030F

    Figure 150: Brazil Hydroxychloroquine and Chloroquine Attractiveness Index, By Route of Administration, By Value, 2015-2030F

    Figure 151: Argentina Hydroxychloroquine and Chloroquine Size, By Value (USD Million), 2015-2030F

    Figure 152: Argentina Hydroxychloroquine and Chloroquine Size, By Type, 2015-2030F

    Figure 153: Argentina Hydroxychloroquine and Chloroquine Share, By Route of Administration, 2015-2030F

    Figure 154: Argentina Hydroxychloroquine and Chloroquine Share, By Application, 2015-2030F

    Figure 155: Argentina Hydroxychloroquine and Chloroquine Attractiveness Index, By Route of Administration, By Value, 2015-2030F

    Figure 156: Colombia Hydroxychloroquine and Chloroquine Size, By Value (USD Million), 2015-2030F

    Figure 157: Colombia Hydroxychloroquine and Chloroquine Size, By Type, 2015-2030F

    Figure 158: Colombia Hydroxychloroquine and Chloroquine Share, By Route of Administration, 2015-2030F

    Figure 159: Colombia Hydroxychloroquine and Chloroquine Share, By Application, 2015-2030F

    Figure 160: Colombia Hydroxychloroquine and Chloroquine Share, By Strength, 2015-2030F

    Figure 161: Colombia Hydroxychloroquine and Chloroquine Attractiveness Index, By Route of Administration, By Value, 2015-2030F